Details
Category: Volume 10 Issue 03 March 2022
Hits: 716

Title: Age and cardiovascular risks in a market population in Southeast Nigeria

Authors: Innocent Chukwuemeka Okoye, Ernest Ndukaife Anyabolu, Sylvia Toochukwu Echendu, Chinyelu Uchenna Ufoaroh, Desmond Onyebuchukwu Ekeh, Anulika Nkechinyere Chukwumobi, Esther N Umeadi

 DOI: https://dx.doi.org/10.18535/jmscr/v10i3.01

Abstract

Background: Globally, cardiovascular risks constitute a heavy healthcare burden, affecting people of different ages in both the developed and the developing ones. Cardiovascular risks and differences in age have not been completely defined.

Objectives: This study was set out to evaluate the influence of age on the risks of cardiovascular disease in Awka, Nigeria.

Methodology: This was a cross-sectional study conducted in an unstructured market workers’ population. The subjects were classified according to their age and screened for cardiovascular risks. The cardiovascular risks were compared between the different age groups.

Results: The study subjects were 294. Females were 72.1% and males 27.9%. Their mean age was 43.13 ± 15.38 years, body mass index (BMI) 28.1 ± 6.0kg/m2), systolic blood pressure (SBP) 129.3 ± 23.7mmHg and diastolic blood pressure (DBP) 82.6 ± 14.7mmHg Majority (98.6%) of the study subjects were Igbos, whereas only 1.4% were Hausas. Tobacco prevalence was 5.4%. Those in the age group of 50-59 years had the highest prevalence of tobacco use (37.5%), followed by those of 30-39 years (25.0%) and 60-69 years (25.0%), p=0.026.Thickened arterial wall had a prevalence of 27.2%. It was high, 42.5%, in those aged 50-59 years, followed by 25.0% in those 60-69 years, p<0.001.Nighttime sleep duration (NTSD)<4hours had a prevalence of 5.4%. Those in the age groups of 30-39 years and 60-69 years had a prevalence of 37.5% of NTSD<4 hours, p=0.002.The prevalence of diabetes mellitus (DM) was 9.5%. The subjects in the age group of 50-59 years had the highest prevalence of DM of 50.0%, followed by 35.7% in those aged 60-69 years, p<0.001. The prevalence of GSM night use was 63.3%. In those aged 20-29 years it was high 25.8% but declined with increasing age, p=0.001. Underweight had a prevalence of 34.0% and occurred in 33.5% of the subjects aged 30-39 years, 50-59 years and 70-79 years. The prevalence of overweight was 28.8% and tended to decline with increasing age. However, obesity increased with age, and was high, 30.0%, in those in the age group of 30-39 years, but declined with increasing age, p=0.002.SBP had a prevalence of 41.5%. SBP of 32.8% was high among the subjects aged 50-59 years, increasing with age initially, p<0.001.The prevalence of DBP was 32.7%, and increased with age to peak at 50-59 years (31.3%), but declined at age >50-59 years, p<0.001.Cigarette smoking p=0.820, alcohol use, p=o.274, and seaster, p=0.210, had insignificant association with age.

Conclusion: The prevalence of tobacco use, thickened arterial wall, diabetes mellitus, systolic blood pressure and diastolic blood pressure was high among those in the age group 50-59 years, whereas nighttime sleep duration <4 hours, underweight and obesity was high among those aged 30-39years. GSM midnight use was common among those aged 20-29years in this study.

Keywords: Age, Tobacco, Thickened arterial wall, Diabetes mellitus, Hypertension, Nighttime sleep deprivation, Obesity.

References

  1. Farley A, McLafferty E, Hendry C. The cardiovascular System. Nurs Stand 2012; 27:34-9.
  2. World Health Organization. Health Fact Sheet for cardiovascular diseases. June, 2021. Accessed January, 2022.
  3. GBD 2017 causes of death, collaborators, global, regional and national age-sex- specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for global burden of disease study 2017. Lancet 2018; 392:1736-88.
  4. Rich MW, Chyun DA, Skolnick AH Et al. Knowledge gaps in the cardiovascular of the older adult population: A scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. J Am Coll Cardiol 2016; 687:2419-40.
  5. Curtis AB, Karki R, Hattoum A, Sharma UC. Arrhythmias in patients ≥80 years of Age: pathophysiology, Management, and Outcomes. J Am Coll Cardiol 2018; 71:2041-57.
  6. North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res 2012; 110:1097-108.
  7. Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: Morbidity, mortality and costs. Clin Geriatr Med 2009; 25:563-77.
  8. Steeman M, Lance G. Cardiac aging and heart disease in humans. Biophys Rev 2017; 9:131-137.
  9. Meschiari CA, Ero OK,Pan H, Finkel T, Lindsey ML. The impact of aging on cardiac extracellular matrix. Geroscience 2017; 39:7-18.
  10. Madhavan MV, Gersh BJ, Alexander KP, Granger CB, Stone GW. Coronary artery disease in patients ≥80 years of age. J Am Coll Cardiol 2018; 7:12015-40.
  11. Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement Cardiol Clin 2010;28:571-86.
  12. Whitworth JA. World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension. 2003; 21(11): 1983–1992.
  13. WHO (1995) Physical Status: The Use and Interpretation of Anthropometry. Technical Report Series 854, 1-1-9950. World Health Organization, Geneva.
  14. Townsend L, Flisher AJ, Gilreath T, King GA. A systemic literature review of tobacco use among adults 15 years and older in Subsaharan Africa. Drug Alcohol Depend 2006; 81:14-27.
  15. 15Global Adult Tobacco Survey: Country report 2012. World Health Organization. http//www.who.int/tobacco/sc. Accessed Feb 8, 2022.
  16. Aniwada EC, Uleanya ND, Ossai ED, Nwobi EA, Anibueze M. Tobacco use: Prevalence, pattern and predictors among those aged 15-49years in Nigeria- a secondary analysis. Tob Induc Dis 2018; 16:7. Doi: https://doi.org/10.18332/tid/82926.
  17. Scollo M, Windstanley M. Tobacco in Ausralia: facts and issues, Melbourne :Cancer Council Victoria.2018.
  18. Moore S, Texeira A, Stewart S. Effect of network social capital on the chances of smoking relapse: A 2year follow up study of urban dwelling adults. Am J Public Health 2014;104:e72-6.
  19. Drope J, Schluger N, Cahn S, Drope J, Hamill S, Islami F et al. Tobacco Atlas 6TH Atlanta: American Cancer Society and Vital Strategies2018.
  20. 20Sreeramareddy CT, Ramakri Shnareddy N, Harsha Kumar H, Sathian B, Arokiasamy JT. Prevalence, distribution and correlates of tobacco smoking and chewing in Nepal: a secondary data analysis of Nepal Demographic and Health Survey 2006. Substance Abuse Treatment, Prevention and Policy 2011;6. doi:10.1186/1747-597X-6-33.
  21. Idris SH, Sambo MN. Psychoactive substance use among in-school adolescents in Zaria, North Western Nigeria: what are the triggers? Niger J Med; 18:291-4.
  22. 22Pierce JP, Whit MV, Emery SL. What public healthcare needed to reduce smoking initiation? Tob Control 2012; 21:258-64.
  23. Funatogawa I, Funatogawa T, Yano E. Impacts of early smoking initiation: Long term trend of lung cancer mortality and smoking initiation from repeated cross-sectional surveys in Great Britain. BMJ open 2012;22e167 British Medical Journal Publishing Group.
  24. Okpataku CT. Pattern and reasons for substance use among long distance drivers in a Nierian city. Indian J Public Health 2015; 59:259-63.
  25. Mak kk, Ho Sy, Day JR. Smoking parents and best friend- independent and combined effects on adolescent smoking and intention to initiate and quit smoking. Nicotine Tob Res 2012;14: 1057-64.
  26. Lewinsohn PM, Brown RA, Seeley JR, Ramsey SE. Psychosocial correlates of cigarette smoking abstinence, experimentation, persistence and frequency during adolescence.  Nicotine Tob Res. 2000; 2:121–131.
  27. Teo KK, Ounpuu S, Hawken S, et al. ; INTERHEART Study Investigators Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368(9536):647–658.
  28. Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ. 2009;339: b3060.
  29. Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur J Cardiovasc Prev Rehabil. 2004;11(2):101–112.
  30. Mdege ND, Shah S, Ayo-Yusuf OA, Hakim J, Siddiqi K. Tobacco use among people living with HIV: Analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries. Lancet Glob Health. 2017;5(6):e578–e592.
  31. Collaborators GBDA. Alcohol use and burden of 195 countries and territories 1990-2016.: A systematic analysis for the global burden of disease study 2016. Lancet 2018; 292:1015-35.
  32. Adelekan ML, Abiodun OA, Obayan AO, Oni G, Ogunremi, OO. Prevalence and Pattern of Substance Use among Undergraduates in a Nigerian University. Drug and Alcohol Dependence 1992; 29:255-261.
  33. Wood AM, Kaptoye S, Butterworth AS, Willeit P, Waranakula S, Botton T et al. Emerging risk factors Collaboration/ Epic-CVD/ UK Biolank Alcohol study Group. Risk thresholds for alcohol consumption: combined analysis of individual participant data for 599912 current drinkers in 83 prospective studies. Lancet 2018; 391: 1513-23.
  34. Larson SC, Wallin A, Wolk A, Markus HJ. Differing association of alcohol consumption with different stroke type: Asystemic review and metaanalysis. BMC Med 2016; 14:178. doi :10.1186/s/12916-016-0721-4.
  35. Larson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose response metaanalysis. J Am Coll Cardiol 2014; 64:281-9.
  36. Ronksley PE, Brien SE, Turner PJ, Mukamal KJ, Ghals WA. Association of alcohol consumption with selected cardiovascular disease outcomes: A systemic review and metaanalysis. BMJ 2011;342: d671. doi:10.1136[BMJ. D671].
  37. Tellides G, Pober JS. Inflammatory and immune responses in the arterial Media. Circ Res 2015; 116:312-22.
  38. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Circulation 2003; 107:346-54.
  39. Somers VK, Dyken ME, Mark AL, Abbound FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328:303-7.
  40. Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract2003;62(3):177–185.
  41. Saquib N, Saquib J, Ahmed T, Khanam MA, Cullen MP. Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010. BMC Public Health. 2012; 12:434. 
  42. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci 2001; 4:732-8.
  43. Joo EY, Yoon CW, KOO DL, Kim D, Hong SB. Adverse effect of 24hours sleep deprivation on cognition and stress hormones.J Clin Neurol 2012;8:146-50.
  44. Takase B, Akima T, Uehata A, Ohsuzu F, Kurita A. Effect of chronic stress and sleep deprivation on both flow-mediated dilation in the brachial artery and the intracellular magnesium level in humans. Clin Cardiol 2004; 27:223-7.
  45. June S, Jianwem C, Elsie RP, David FW, Micheal J, Thun MD and Joy L. The effect of age on the association between body mass index and mortality. N Engl J Med 1998; 338:1-7
  46. Franklin SS, Gustin W, Wong ND et al. Haemodynamic patterns of age related changes in blood pressure. The Framingham Heart Study. Circulation 199796308-315. Stott DJ, Bowman A. blood pressure and aging. J Hum Hypertens 200014771-772.

Corresponding Author

Ernest Ndukaife Anyabolu

Department of Medicine, Chukwuemeka Odumegwu Ojukwu University, Awka, Nigeria